🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
VKT
$VKTX
🔒 US EquitiesViking Therapeutics Inc
AVG HISTORICAL GAP
+1.58%
MAX GAP RECORD
+18.20%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $VKTX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$VKTX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 28, 2026 Earnings Release 2026-10-28 (AFTER CLOSE (16:00)) |
-3.88%
|
| Jul 29, 2026 Earnings Release 2026-07-29 (AFTER CLOSE) |
+0.27%
|
| Apr 29, 2026 Earnings Release 2026-04-29 (AFTER CLOSE) |
-2.71%
|
| Feb 11, 2026 Earnings Release 2026-02-11 (AFTER CLOSE) |
+18.20%
|
| Oct 22, 2025 Earnings Release 2025-10-22 (AFTER CLOSE) |
+12.79%
|
| Jul 23, 2025 Earnings Release 2025-07-23 (AFTER CLOSE) |
-5.69%
|
| Apr 23, 2025 Earnings Release 2025-04-23 (AFTER CLOSE) |
+1.16%
|
| Feb 05, 2025 Earnings Release 2025-02-05 (AFTER CLOSE) |
-7.40%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
7.0%
Bullish Gaps (7)
Bearish Gaps (7)
Neutral / Flat (2)
📖 Intelligence Summary
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗